Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ: ELOX · Real-Time Price · USD
15.07
-0.93 (-5.81%)
At close: Aug 28, 2026, 4:00 PM EDT
15.36
+0.29 (1.92%)
After-hours: Aug 28, 2026, 7:53 PM EDT

Eloxx Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-10.65-6-3.14-17.05-36.07-66.73
Depreciation & Amortization
--0.160.810.70.96
Other Amortization
0.020.250.470.260.540.42
Loss (Gain) From Sale of Assets
-0-0-0.04-0.29-0.08
Asset Writedown & Restructuring Costs
----0.0422.67
Stock-Based Compensation
0.340.240.541.973.029.17
Other Operating Activities
-1.46-1.33-0.35-0.880.05-0.54
Change in Accounts Receivable
-2.72-2.72---
Change in Accounts Payable
-2.63-2.63-0.352.681.64-0.32
Change in Other Net Operating Assets
-1.650.440.72-1.84-1.76-0.72
Operating Cash Flow
-16.02-6.33-4.72-14.34-31.85-35
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-----0.07-0.09
Sale of Property, Plant & Equipment
000.040.31--
Cash Acquisitions
-----2.15
Investing Cash Flow
000.040.31-0.072.06

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--0.380.43--
Long-Term Debt Issued
-2.873.67--11.87
Total Debt Issued
0.62.874.050.43-11.87
Short-Term Debt Repaid
--0.3----
Long-Term Debt Repaid
--1.26-0.61-9.4--11.38
Total Debt Repaid
-0.3-1.56-0.61-9.4--11.38
Net Debt Issued (Repaid)
0.31.313.44-8.97-0.49
Issuance of Common Stock
60.34--4.89-47.74
Repurchase of Common Stock
------0.36
Other Financing Activities
16.779.69--8.812.92
Financing Cash Flow
77.41113.44-4.088.8150.79

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
61.394.68-1.24-18.11-23.117.84

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-16.02-6.33-4.72-14.34-31.91-35.09
Free Cash Flow Growth
------
Free Cash Flow Margin
---74.15%---
Free Cash Flow Per Share
-4.28-5.64-13.80-61.37-162.04-220.68
Levered Free Cash Flow
--4.9-3.47-6.47-17.96-14.61
Unlevered Free Cash Flow
--4.49-3.22-6.01-17.28-14.25

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-0.030.140.991.370.73
Change in Working Capital
-4.270.52-2.360.84-0.12-1.04